Tech Company Financing Transactions
Juvenescence Funding Round
Juvenescence, operating out of Tortola, scored $100 million in investment from Grok Ventures and IPGL.
Transaction Overview
Company Name
Announced On
8/20/2019
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Investors
Proceeds Purpose
The Series B financing which provides us with sufficient working capital to progress many of our programs to their initial inflection points.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Craigmuir Chambers PO Box 71 Rd. Town
Tortola, VG1110
British Virgin Islands
Tortola, VG1110
British Virgin Islands
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Juvenescence Limited is a British Virgin Islands-based holding company that invests in human ageing and longevity. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningful extend human healthspan and eventually lifespan.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
James Mellon
Chief Executive Officer
Gregory Bailey
Chief Financial Officer
David Ellam
Chief Medical Officer
Declan Doogan
VP - R & D
Margaret Jackson
Browse more venture capital transactions:
Prev: 8/20/2019: nOCD venture capital transaction
Next: 8/20/2019: Root Insurance venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC transactions on this site are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs